Literature DB >> 8077512

Mycology of nail disorders.

G Midgley1, M K Moore, J C Cook, Q G Phan.   

Abstract

Cases of onychomycosis represent up to 30% of diagnosed superficial fungal infections and are caused by three groups of fungi: dermatophytes, yeasts, and nondermatophytic molds. The majority of toenail infections are caused by dermatophytes; Trichophyton rubrum is isolated with the greatest frequency. In infections of fingernails, Candida species can be isolated as frequently as the dermatophytes. Of the molds, Scytalidium species can infect both fingernails and toenails, as well as adjacent skin, and represent 3% of the nail infections in a temperate country such as the United Kingdom but a much higher proportion in tropical countries. Other molds such as Scopulariopsis, Acremonium, and Aspergillus species can infect damaged nails. The isolation of a dermatophyte is always considered indicative of infection, but the presence of other molds, which may be aerial contaminants, must be interpreted with care.

Entities:  

Mesh:

Year:  1994        PMID: 8077512     DOI: 10.1016/s0190-9622(08)81272-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  23 in total

Review 1.  Onychomycosis in the elderly.

Authors:  A K Gupta
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

2.  A health-related quality of life measure for use in patients with onychomycosis: a validation study.

Authors:  D P Lubeck; D Gause; J R Schein; L E Prebil; L P Potter
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

3.  Cost of treatment for onychomycosis. Data from a 9-month observational study.

Authors:  D M Stier; C Henke; J Schein; J Doyle; W H Schonfeld; J Broering
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  Study of onychomycosis in Córdoba, Spain: prevailing fungi and pattern of infection.

Authors:  A Vélez; M J Linares; J C Fenández-Roldán; M Casal
Journal:  Mycopathologia       Date:  1997       Impact factor: 2.574

Review 5.  Terbinafine. A pharmacoeconomic evaluation of its use in superficial fungal infections.

Authors:  R Davis; J A Balfour
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

6.  Onychomycosis in Rome, Italy.

Authors:  R Mercantini; R Marsella; D Moretto
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

Review 7.  Which antifungal agent for onychomycosis? A pharmacoeconomic analysis.

Authors:  V N Joish; E P Armstrong
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 8.  Treatment and prophylaxis of tinea infections.

Authors:  G E Piérard; J E Arrese; C Piérard-Franchimont
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

9.  Comparison of diagnostic methods in the evaluation of onychomycosis.

Authors:  Iman Haghani; Tahereh Shokohi; Zohreh Hajheidari; Alireza Khalilian; Seyed Reza Aghili
Journal:  Mycopathologia       Date:  2013-02-01       Impact factor: 2.574

10.  Evaluation of clinicomycological aspects of onychomycosis.

Authors:  Ravinder Kaur; Bineeta Kashyap; Rati Makkar
Journal:  Indian J Dermatol       Date:  2008       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.